Consistency among different PSMA ligands for defining PSMA-overexpression prior to PSMA-targeted therapy in prostate cancer

被引：0
|
作者：
Heilinger, Jan [1 ,2 ]
Weindler, Jasmin [3 ]
Roth, Katrin [1 ,2 ]
Krapf, Philipp [4 ]
Neumaier, Bernd [5 ,6 ]
Schomaecker, Klaus
Dietlein, Markus
Drzezga, Alexander [7 ,8 ]
Kobe, Carsten
机构：
[1] Univ Cologne, Fac Med, Dept Nucl Med, Cologne, Germany
[2] Univ Cologne, Univ Hosp Cologne, Cologne, Germany
[3] Univ Cologne, Dept Nucl Med, Cologne, Germany
[4] INM 5, Julich, Germany
[5] Univ Cologne, Inst Radiochem & Expt Mol Imaging, Cologne, Germany
[6] Forschungszentrum Julich, Nucl Chem, Inst Neurosci & Med INM 5, Julich, Germany
[7] Univ Hosp Cologne, Dept Nucl Med, Cologne, Germany
[8] Inst Neurosci & Med INM 2, Mol Org Brain, Julich, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2024年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
241353
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Prostate-specific Membrane Antigen (PSMA) Expression in the Neovasculature of Gynecologic Malignancies: Implications for PSMA-targeted Therapy
    Wernicke, Alla G.
    Kim, Sae
    Liu, He
    Bander, Neil H.
    Pirog, Edyta C.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2017, 25 (04) : 271 - 276
  • [42] Current status of PSMA-targeted imaging and therapy
    Wang, Hui
    Li, GuanNan
    Zhao, Jie
    Eiber, Matthias
    Tian, Rong
    FRONTIERS IN ONCOLOGY, 2024, 13
  • [43] A PSMA-targeted theranostic agent for photodynamic therapy
    Chen, Ying
    Chatterjee, Samit
    Lisok, Ala
    Minn, Il
    Pullambhatla, Mrudula
    Wharram, Bryan
    Wang, Yuchuan
    Jin, Jiefu
    Bhujwalla, Zaver M.
    Nimmagadda, Sridhar
    Mease, Ronnie C.
    Pomper, Martin G.
    JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2017, 167 : 111 - 116
  • [44] Heterogeneous tumor PSMA expression represents a resistance mechanism to PSMA-targeted radioligand therapy
    Lueckerath, Katharina
    Current, Kyle
    Meyer, Catherine
    Magyar, Clara
    Mona, Christine E.
    Almajano, Joel
    Slavik, Roger
    Stuparu, Andreea D.
    Cheng, Chloe
    Dawson, David
    Radu, Caius
    Czernin, Johannes
    CANCER RESEARCH, 2020, 80 (16)
  • [45] PSMA-targeted radiopharmaceutical therapy in patients with metastatic castration-resistant prostate cancer
    Hope, Thomas A.
    Calais, Jeremie
    LANCET, 2021, 397 (10276): : 768 - 769
  • [46] Status of PSMA-targeted radioligand therapy in prostate cancer: current data and future trials
    Jang, Albert
    Kendi, Ayse T.
    Sartor, Oliver
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [47] PSMA-targeted radioligand therapy in metastatic prostate cancer: Comprehensive analysis of recent evidence
    Ovcaricek, Petra Petranovic
    Garo, Maria Luisa
    Giovanella, Luca
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, 52 (04) : 1242 - 1245
  • [48] Self-Assembled PSMA-Targeted Nanoparticles Enhanced Photodynamic Therapy in Prostate Cancer
    Deng, Yongming
    Zhang, Qing
    Liu, Guangxiang
    Lin, Tingsheng
    Zhang, Wenlong
    He, Xin
    Lu, Wenfeng
    Ding, Yuanzhen
    Cao, Wenmin
    Guo, Hongqian
    JOURNAL OF NANOMATERIALS, 2022, 2022
  • [49] Development, Characterization, and Evaluation of PSMA-Targeted Glycol Chitosan Micelles for Prostate Cancer Therapy
    Xu, Jing
    Yu, Jingmou
    Xu, Xiao
    Wang, Liangliang
    Liu, Yonghua
    Li, Lixin
    Zhao, Jianguo
    He, Ming
    JOURNAL OF NANOMATERIALS, 2014, 2014
  • [50] PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617
    Kratochwil, Clemens
    Giesel, Frederik L.
    Stefanova, Melsa
    Benesova, Martina
    Bronzel, Marcus
    Afshar-Oromieh, Ali
    Mier, Walter
    Eder, Matthias
    Kopka, Klaus
    Haberkorn, Uwe
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (08) : 1170 - 1176
12345